Table 3.
Gene | CpGs | Methylation levela | T2DM patients vs. healthy controls | |
---|---|---|---|---|
OR (95% CI)b | P-valueb | |||
NLRP3 | Total methylation | ≧0.764 | Ref. | |
<0.764 | 1.08 (0.52~2.24) | 0.804 | ||
Per SD less methylation | 1.14 (0.78~1.65) | 0.499 | ||
CpG1 | ≧0.823 | Ref. | ||
<0.823 | 0.47 (0.22~1.02) | 0.056 | ||
Per SD less methylation | 0.98 (0.68~1.43) | 0.924 | ||
CpG2 | ≧0.778 | Ref. | ||
<0.778 | 1.77 (0.84~3.73) | 0.132 | ||
Per SD less methylation | 1.14 (0.78~1.66) | 0.498 | ||
CpG3 | ≧0.851 | Ref. | ||
<0.851 | 0.99 (0.48~2.07) | 0.988 | ||
Per SD less methylation | 0.97 (0.66~1.41) | 0.860 | ||
CpG4 | ≧0.607 | Ref. | ||
<0.607 | 1.44 (0.69~3.03) | 0.332 | ||
Per SD less methylation | 1.37 (0.92~2.04) | 0.118 | ||
AIM2 | Total methylation | ≧0.968 | Ref. | |
<0.968 | 2.29 (1.28~6.66) | 0.011* | ||
Per SD less methylation | 1.40 (0.94~2.07) | 0.096 | ||
CpG2 | ≧0.911 | Ref. | ||
<0.911 | 0.91 (0.42~1.97) | 0.808 | ||
Per SD less methylation | 1.16 (0.80~1.68) | 0.446 | ||
CpG3 | =1.000 | Ref. | ||
<1.000 | 8.29 (3.37~20.40) | <0.001** | ||
Per SD less methylation | 1.72 (1.06~2.80) | 0.029* | ||
ASC | Total methylation | ≧0.929 | Ref. | |
<0.929 | 1.21 (0.56~2.61) | 0.621 | ||
Per SD less methylation | 1.10 (0.75~1.59) | 0.641 | ||
CpG1 | ≧0.912 | Ref. | ||
<0.912 | 1.35 (0.62~2.93) | 0.453 | ||
Per SD less methylation | 1.17 (0.80~1.69) | 0.426 | ||
CpG2 | ≧0.951 | Ref. | ||
<0.951 | 1.14 (0.53~2.43) | 0.741 | ||
Per SD less methylation | 0.96 (0.66~1.41) | 0.844 | ||
CpG3 | ≧0.922 | Ref. | ||
<0.922 | 1.30 (0.61~2.78) | 0.504 | ||
Per SD less methylation | 1.13 (0.78~1.64) | 0.511 |
Median of total or each CpG methylation in healthy controls.
OR, P-values were from logistic regression analyses controlling for BMI.
P < 0.05,
P < 0.001; The bold in the table means statistically significant. (P < 0.05).
Per SD less methylation, the decrease of per standard deviation of CpG methylation, the change of OR value.